Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-23-034859
Filing Date
2023-09-29
Accepted
2023-09-29 16:30:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 187036
2 form424b3_001.jpg GRAPHIC 20924
3 form424b3_002.jpg GRAPHIC 49940
  Complete submission text file 0001493152-23-034859.txt   285968
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-269088 | Film No.: 231296163
SIC: 2834 Pharmaceutical Preparations